Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Changes in body mass index during treatment of childhood acute lymphoblastic leukemia with the Nordic ALL2008 protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Healthcare Resource Utilization in Patients with Myeloproliferative Neoplasms: A Danish Nationwide Matched Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Morten K Larsen
  • Vibe Skov
  • Lasse Kjaer
  • Natascha A Møller-Palacino
  • Rasmus K Pedersen
  • Morten Andersen
  • Johnny T Ottesen
  • Sabrina Cordua
  • Henrik E Poulsen
  • Morten Dahl
  • Trine A Knudsen
  • Christina Schjellerup Eickhardt-Dalbøge
  • Steffen Koschmieder
  • Kasper M Pedersen
  • Yunus Çolak
  • Stig E Bojesen
  • Børge G Nordestgaard
  • Thomas Stiehl
  • Hans C Hasselbalch
  • Christina Ellervik
View graph of relations

The myeloproliferative neoplasms are associated with chronic kidney disease but whether clonal haematopoiesis of indeterminate potential (CHIP) is associated with impaired kidney function is unknown. In the Danish General Suburban Population Study (N = 19 958) from 2010 to 2013, 645 individuals were positive for JAK2V617F (N = 613) or CALR (N = 32) mutations. Mutation-positive individuals without haematological malignancy were defined as having CHIP (N = 629). We used multiple and inverse probability weighted (IPW)-adjusted linear regression analysis to estimate adjusted mean (95% confidence interval) differences in estimated glomerular filtration rate (eGFR; ml/min/1.73 m2 ) by mutation status, variant allele frequency (VAF%), blood cell counts, and neutrophil-to-lymphocyte ratio (NLR). We performed 11-year longitudinal follow-up of eGFR in all individuals. Compared to CHIP-negative individuals, the mean differences in eGFR were -5.6 (-10.3, -0.8, p = .02) for CALR, -11.9 (-21.4, -2.4, p = 0.01) for CALR type 2, and -10.1 (-18.1, -2.2, p = .01) for CALR with VAF ≥ 1%. The IPW-adjusted linear regression analyses showed similar results. NLR was negatively associated with eGFR. Individuals with CALR type 2 had a worse 11-year longitudinal follow-up on eGFR compared to CHIP-negative individuals (p = .004). In conclusion, individuals with CALR mutations, especially CALR type 2, had impaired kidney function compared to CHIP-negative individuals as measured by a lower eGFR at baseline and during 11-year follow-up.

Original languageEnglish
JournalEuropean Journal of Haematology
Volume109
Issue number5
Pages (from-to)576-585
Number of pages10
ISSN0902-4441
DOIs
Publication statusPublished - Nov 2022

Bibliographical note

© 2022 The Authors. European Journal of Haematology published by John Wiley & Sons Ltd.

    Research areas

  • Calreticulin/genetics, Clonal Hematopoiesis/genetics, Denmark/epidemiology, Follow-Up Studies, Humans, Janus Kinase 2/genetics, Kidney/metabolism, Mutation, Thrombocythemia, Essential/genetics

ID: 80634369